Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-026036
Filing Date
2017-11-13
Accepted
2017-11-13 16:29:47
Documents
1
Period of Report
2017-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8767
  Complete submission text file 0000899243-17-026036.txt   10452
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET SUITE 3310 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 3310 BOSTON MA 02199 617-391-0403
AJU IB Investment Co., Ltd. (Reporting) CIK: 0001710065 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 171196312